切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (02) : 308 -313. doi: 10.3877/cma.j.issn.2095-3232.2025031

综述

肝血管瘤临床治疗进展
潘佰猛1, 张挽乾1, 张秋雨1, 曹芮1, 李鹏1, 张维桢1, 张灵强1,2,()   
  1. 1. 810001 西宁,青海大学医学院
    2. 810001 西宁,青海大学附属医院肝胆胰外科
  • 收稿日期:2024-10-20 出版日期:2025-04-10
  • 通信作者: 张灵强

Progress in clinical treatment of hepatic hemangioma

Baimeng Pan1, Wanqian Zhang1, Qiuyu Zhang1, Rui Cao1, Peng Li1, Weizhen Zhang1, Lingqiang Zhang1,2,()   

  1. 1. Qinghai University Medical College,Xining 810001,China
    2. Department of Hepatobiliary and Pancreatic Surgery,Affiliated Hospital of Qinghai University,Xining 810001,China
  • Received:2024-10-20 Published:2025-04-10
  • Corresponding author: Lingqiang Zhang
引用本文:

潘佰猛, 张挽乾, 张秋雨, 曹芮, 李鹏, 张维桢, 张灵强. 肝血管瘤临床治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 308-313.

Baimeng Pan, Wanqian Zhang, Qiuyu Zhang, Rui Cao, Peng Li, Weizhen Zhang, Lingqiang Zhang. Progress in clinical treatment of hepatic hemangioma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(02): 308-313.

肝血管瘤(HH)是临床上最常见的肝脏良性肿瘤,随着医疗技术的进步,其检出率逐年增加,临床上对于肝血管瘤的治疗也越来越重视,近年来越来越多的新疗法、新技术应用于肝血管瘤的治疗且取得了不错的效果。本文旨在对HH 常见的治疗方法进行综述,以期为临床工作者提供治疗参考。

Hepatic hemangioma (HH) is the most common benign tumor of the liver in clinical practice.With the progress in medical technology, the diagnostic rate of HH has been increased year by year,and extensive attention has been diverted to clinical treatment of HH.In recent years, more and more novel therapies and technologies have been applied to treat HH and achieve excellent effect.In this article, common treatment methods of HH were reviewed, aiming to provide treatment reference for clinicians.

[1]
Leon M, Chavez L, Surani S.Hepatic hemangioma: what internists need to know[J].World J Gastroenterol, 2020, 26(1): 11-20.DOI:10.3748/wjg.v26.i1.11.
[2]
Bajenaru N, Balaban V, Săvulescu F, et al.Hepatic hemangioma:review[J].J Med Life, 2015, 8 Spec Issue: 4-11.
[3]
Belghiti J, Cauchy F, Paradis V, et al.Diagnosis and management of solid benign liver lesions[J].Nat Rev Gastroenterol Hepatol, 2014,11(12): 737-749.DOI: 10.1038/nrgastro.2014.151.
[4]
Oldhafer KJ, Habbel V, Horling K, et al.Benign liver tumors[J].Visc Med, 2020, 36(4): 292-303.DOI: 10.1159/000509145.
[5]
Donati M, Stavrou GA, Donati A, et al.The risk of spontaneous rupture of liver hemangiomas: a critical review of the literature[J].J Hepatobiliary Pancreat Sci, 2011, 18(6): 797-805.DOI: 10.1007/s00534-011-0420-7.
[6]
Gupta S, Agarwal V, Acharya AN.Spontaneous rupture of a giant hepatic hemangioma-report of a case[J].Indian J Surg, 2012, 74(5):434-436.DOI: 10.1007/s12262-011-0309-3.
[7]
Kamath SM, Mysorekar VV, Kadamba P.Hepatic angiosarcoma developing in an infantile hemangioendothelioma: a rare case report[J].J Cancer Res Ther, 2015, 11(4): 1022.DOI: 10.4103/0973-1482.146132.
[8]
Iacobas I, Phung TL, Adams DM, et al.Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring[J].J Pediatr, 2018, 203: 294-300.e2.DOI: 10.1016/j.jpeds.2018.08.012.
[9]
姚伟, 李凯, 董岿然, 等.婴幼儿肝血管瘤82例分类特点及疗效分析[J].中华小儿外科杂志, 2018, 39(10): 739-743.DOI: 10.3760/cma.j.issn.0253-3006.2018.10.005.Yao W, Li K, Dong KR, et al.Classification characteristics and therapeutic efficacies of hepatic hemangioma: a report of 82 cases[J].Chin J Pediatr Surg, 2018, 39(10): 739-743.DOI: 10.3760/cma.j.issn.0253-3006.2018.10.005.
[10]
Aziz H, Brown ZJ, Eskander MF, et al.A scoping review of the classification, diagnosis, and management of hepatic adenomas[J].J Gastrointest Surg, 2022, 26(4): 965-978.DOI: 10.1007/s11605-022-05246-8.
[11]
Dane B, Shanbhogue K, Menias CO, et al.The humbling hemangioma:uncommon CT and MRI imaging features and mimickers of hepatic hemangiomas[J].Clin Imaging, 2021, 74: 55-63.DOI: 10.1016/j.clinimag.2020.12.028.
[12]
Colakoğlu O, Taşkiran B, Yazici N, et al.Safety of biopsy in liver hemangiomas[J].Turk J Gastroenterol, 2005, 16(4): 220-223.
[13]
Dong J, Zhang M, Chen JQ, et al.Tumor size is not a criterion for resection during the management of giant hemangioma of the liver[J].Eur J Gastroenterol Hepatol, 2015, 27(6): 686-691.DOI: 10.1097/MEG.0000000000000344.
[14]
Klotz T, Montoriol PF, Da Ines D, et al.Hepatic haemangioma:common and uncommon imaging features[J].Diagn Interv Imaging,2013, 94(9): 849-859.DOI: 10.1016/j.diii.2013.04.008.
[15]
Li J, Huang L, Liu C, et al.New recognition of the natural history and growth pattern of hepatic hemangioma in adults[J].Hepatol Res, 2016,46(8): 727-733.DOI: 10.1111/hepr.12610.
[16]
Liu X, Yang Z, Tan H, et al.Patient age affects the growth of liver haemangioma[J].HPB, 2018, 20(1): 64-68.DOI: 10.1016/j.hpb.2017.08.021.
[17]
国际肝胆胰协会中国分会肝血管瘤专业委员会.肝血管瘤诊断和治疗多学科专家共识(2019版)[J].临床肝胆病杂志, 2019, 35(9):1928-1932.Hepatic Hemangioma Professional Committee of China Branch of International Hepato-Pancreato-Biliary Association.Multidisciplinary expert consensus on the diagnosis and treatment of hepatic hemangioma ( 2019 edition)[J].J Clin Hepatol,2019,35( 9) : 1928-1932.
[18]
Kacała A, Dorochowicz M, Matus I, et al.Hepatic hemangioma:review of imaging and therapeutic strategies[J].Medicina, 2024,60(3): 449.DOI: 10.3390/medicina60030449.
[19]
Li L, Xu L, Wang P, et al.Advantages of laparoscopic hepatic hemangioma surgery in quality of life: a prospective study[J].Surg Endosc,2022, 36(12): 8967-8974.DOI: 10.1007/s00464-022-09348-x.
[20]
Liu Y, Wei X, Wang K, et al.Enucleation versus anatomic resection for giant hepatic hemangioma: a meta-analysis[J].Gastrointest Tumors,2017, 3(3-4): 153-162.DOI: 10.1159/000455846.
[21]
隋承军, 杨甲梅.肝血管瘤诊治进展[J].中国实用外科杂志, 2009,29(11): 949-952.DOI:10.3321/j.issn.1005-2208.2009.11.026.
[22]
Ghosh NK, RR, Singh A, et al.Surgery for symptomatic hepatic hemangioma: resection vs.enucleation, an experience over two decades[J].Ann Hepatobiliary Pancreat Surg, 2023, 27(3): 258-263.DOI: 10.14701/ahbps.22-130.
[23]
Xie QS, Chen ZX, Zhao YJ, et al.Outcomes of surgery for giant hepatic hemangioma[J].BMC Surg, 2021, 21(1): 186.DOI: 10.1186/s12893-021-01185-4.
[24]
李世思, 陈章彬, 郭志唐, 等.腹腔镜下不同术式治疗巨大肝血管瘤的疗效分析[J].腹腔镜外科杂志, 2022, 27(5): 332-336.DOI:10.13499/j.cnki.fqjwkzz.2022.05.332.Li SS, Chen ZB, Guo ZT, et al.Efficacy analysis of laparoscopic hemangioma enucleation and anatomical hepatectomy in the treatment of giant hepatic hemangioma[J].J Laparosc Surg, 2022, 27(5): 332-336.DOI: 10.13499/j.cnki.fqjwkzz.2022.05.332.
[25]
Cheng WL, Qi YQ, Wang B, et al.Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis[J].Ann R Coll Surg Engl, 2017, 99(3): 237-241.DOI: 10.1308/rcsann.2016.0349.
[26]
Kim SH, Kim KH, Kirchner VA, et al.Pure laparoscopic right hepatectomy for giant hemangioma using anterior approach[J].Surg Endosc, 2017, 31(5): 2338-2339.DOI: 10.1007/s00464-016-5224-z.
[27]
刘笑雷, 杨志英, 谭海东, 等.肝脏巨大血管瘤术中大出血的危险因素[J].中华肝胆外科杂志, 2017, 23(7): 433-436.DOI: 10.3760/cma.j.issn.1007-8118.2017.07.001.Liu XL, Yang ZY, Tan HD, et al.Risk factors of massive blood loss during resection of giant liver hemangioma[J].Chin J Hepatobiliary Surg, 2017, 23(7): 433-436.DOI: 10.3760/cma.j.issn.1007-8118.2017.07.001.
[28]
郭志唐, 龙奎, 王琳, 等.精准肝切除理念在腹腔镜下Ⅰ型肝血管瘤剥除术中的应用[J].重庆医学, 2021, 50(5): 749-752.DOI:10.3969/j.issn.1671-8348.2021.05.007.Guo ZT, Long K, Wang L, et al.Application of the concept of precise hepatectomy in laparoscopic hepatic hemangioma dissection of typeⅠhepatic hemangioma[J].Chongqing Med, 2021, 50(5): 749-752.DOI:10.3969/j.issn.1671-8348.2021.05.007.
[29]
Prodromidou A, Machairas N, Garoufalia Z, et al.Liver transplantation for giant hepatic hemangioma: a systematic review[J].Transplant Proc, 2019, 51(2): 440-442.DOI: 10.1016/j.transproceed.2019.01.018.
[30]
Shankar S, Rammohan A, Kulaseharan VH, et al.Liver transplantation for rapidly progressive giant hepatic hemangioma with diffuse hemangiomatosis[J].Exp Clin Transplant, 2021, 19(10): 1106-1109.DOI: 10.6002/ect.2020.0330.
[31]
Zhao Y, Legan CE.Liver transplantation for giant hemangioma complicated by kasabach-Merritt syndrome: a case report and literature review[J].Am J Case Rep, 2022, 23: e936042.DOI:10.12659/AJCR.936042.
[32]
荆良, 周伟平, 吴孟超.肝海绵状血管瘤的治疗进展[J].肝胆胰外科杂志, 2006, 18(2): 122-123, 126.DOI: 10.3969/j.issn.1007-1954.2006.02.026.
[33]
Xu L, Wu S, Kong J, et al.Thermal ablation of hepatic hemangioma:a multi-center experience with long-term outcomes[J].Eur J Radiol,2023, 164: 110842.DOI: 10.1016/j.ejrad.2023.110842.
[34]
Li F, Xing H.Effectiveness of microwave ablation for the treatment of hepatic hemangioma - meta-analysis and meta-regression[J].Int J Hyperthermia, 2023, 40(1): 2146214.DOI: 10.1080/02656736.2022.2146214.
[35]
Wu S, Gao R, Yin T, et al.Complications of radiofrequency ablation for hepatic hemangioma: a multicenter retrospective analysis on 291 cases[J].Front Oncol, 2021, 11: 706619.DOI: 10.3389/fonc.2021.706619.
[36]
Kong J, Gao R, Wu S, et al.Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching[J].Eur Radiol,2022, 32(5): 3309-3318.DOI: 10.1007/s00330-021-08425-4.
[37]
Wen SQ, Wan M, Len KM, et al.Safety and efficacy of laparoscopic radiofrequency ablation for hepatic hemangiomas: a multicenter retrospective study[J].Ann Hepatol, 2018, 17(2): 268-273.DOI:10.5604/01.3001.0010.8653.
[38]
Zhang X, Yan L, Li B, et al.Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study[J].Surg Endosc, 2016, 30(2):756-763.DOI: 10.1007/s00464-015-4274-y.
[39]
Qu C, Liu H, Li XQ, et al.Percutaneous ultrasound-guided ‘threestep’radiofrequency ablation for giant hepatic hemangioma (5-15 cm):a safe and effective new technique[J].Int J Hyperthermia, 2020, 37(1):212-219.DOI: 10.1080/02656736.2020.1732484.
[40]
Gao J, Ji JS, Ding XM, et al.Laparoscopic radiofrequency ablation for large subcapsular hepatic hemangiomas: technical and clinical outcomes[J].PLoS One, 2016, 11(2): e0149755.DOI: 10.1371/journal.pone.0149755.
[41]
Li J, Zhang S, Ning C, et al.Efficacy of radiofrequency ablation vs.transcatheter arterial embolization for hepatic hemangiomas[J].Eur J Gastroenterol Hepatol, 2024, 36(6): 750-757.DOI: 10.1097/MEG.0000000000002724.
[42]
Tak WY, Park SY, Jeon SW, et al.Ultrasonography-guided percutaneous radiofrequency ablation for treatment of a huge symptomatic hepatic cavernous hemangioma[J].J Clin Gastroenterol, 2006, 40(2): 167-170.DOI: 10.1097/01.mcg.0000196404.07487.1d.
[43]
Park SY, Tak WY, Jung MK, et al.Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonographyguided radiofrequency ablation[J].J Hepatol, 2011, 54(3): 559-565.DOI: 10.1016/j.jhep.2010.07.024.
[44]
Ng KK, Lam CM, Poon RT, et al.Safety limit of large-volume hepatic radiofrequency ablation in a rat model[J].Arch Surg, 2006, 141(3):252-258.DOI: 10.1001/archsurg.141.3.252.
[45]
Wang Z, Tang X, Qi X, et al.Feasibility, safety, and efficacy of ultrasound-guided percutaneous microwave ablation for giant hepatic hemangioma[J].Int J Hyperthermia, 2018, 35(1): 246-252.DOI:10.1080/02656736.2018.1493541.
[46]
Tang X, Ding M, Lu B, et al.Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas[J].Int J Hyperthermia, 2019,36(1): 632-639.DOI: 10.1080/02656736.2019.1624837.
[47]
Ziemlewicz TJ, Wells SA, Lubner MA, et al.Microwave ablation of giant hepatic cavernous hemangiomas[J].Cardiovasc Intervent Radiol,2014, 37(5): 1299-1305.DOI: 10.1007/s00270-014-0934-x.
[48]
Liu F, Yu X, Cheng Z, et al.Risk factors for hemoglobinuria after ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous hemangiomas[J].Oncotarget, 2018, 9(39): 25708-25713.DOI: 10.18632/oncotarget.25379.
[49]
Tang XY, Wang Z, Wang T, et al.Efficacy, safety and feasibility of ultrasound-guided percutaneous microwave ablation for large hepatic hemangioma[J].J Dig Dis, 2015, 16(9): 525-530.DOI: 10.1111/1751-2980.12169.
[50]
Shi Y, Song J, Ding M, et al.Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes[J].Int J Hyperthermia, 2020, 37(1): 938-943.DOI:10.1080/02656736.2020.1766122.
[51]
Yamamoto T, Kawarada Y, Yano T, et al.Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization[J].Am J Gastroenterol, 1991, 86(11): 1645-1649.
[52]
Özgür Ö, Sindel HT.Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results[J].Turk J Med Sci, 2021,51(6): 2943-2950.DOI: 10.3906/sag-2102-352.
[53]
Torkian P, Li J, Kaufman JA, et al.Effectiveness of transarterial embolization in treatment of symptomatic hepatic hemangiomas:systematic review and meta-analysis[J].Cardiovasc Intervent Radiol,2021, 44(1): 80-91.DOI: 10.1007/s00270-020-02611-5.
[54]
Ribeiro MA Jr, Papaiordanou F, Gonçalves JM, et al.Spontaneous rupture of hepatic hemangiomas: a review of the literature[J].World J Hepatol, 2010, 2(12): 428-433.DOI: 10.4254/wjh.v2.i12.428.
[55]
Miura JT, Amini A, Schmocker R, et al.Surgical management of hepatic hemangiomas: a multi-institutional experience[J].HPB, 2014,16(10): 924-928.DOI: 10.1111/hpb.12291.
[56]
Corigliano N, Mercantini P, Amodio PM, et al.Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case[J].Surg Today, 2003, 33(6): 459-463.DOI: 10.1007/s10595-002-2514-z.
[57]
Cao Y, Xiong F, Xiong B, et al.A case of spontaneous hepatic hemangioma rupture: Successful management with transarterial chemoembolization alone[J].J Interv Med, 2019, 2(3): 131-133.DOI:10.1016/j.jimed.2019.09.014.
[58]
Liu X, Yang Z, Tan H, et al.Long-term result of transcatheter arterial embolization for liver hemangioma[J].Medicine, 2017, 96(49): e9029.DOI: 10.1097/MD.0000000000009029.
[59]
Szejnfeld D, Nunes TF, Fornazari VAV, et al.Transcatheter arterial embolization for unresectable symptomatic giant hepatic hemangiomas: single-center experience using a lipiodol-ethanol mixture[J].Radiol Bras, 2015, 48(3): 154-157.DOI: 10.1590/0100-3984.2014.0063.
[60]
Giavroglou C, Economou H, Ioannidis I.Arterial embolization of giant hepatic hemangiomas[J].Cardiovasc Intervent Radiol, 2003, 26(1):92-96.DOI: 10.1007/s00270-002-2648-8.
[61]
Li Y, Jia Y, Li S, et al.Transarterial chemoembolization of giant liver haemangioma: a multi-center study with 836 cases[J].Cell Biochem Biophys, 2015, 73(2): 469-472.DOI: 10.1007/s12013-015-0680-y.
[62]
Firouznia K, Ghanaati H, Alavian SM, et al.Management of liver hemangioma using trans-catheter arterial embolization[J].Hepat Mon,2014, 14(12): e25788.DOI: 10.5812/hepatmon.25788.
[63]
MacDonald A, Durkin N, Deganello A, et al.Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience[J].Ann Surg, 2022, 275(1): e250-e255.DOI:10.1097/SLA.0000000000003881.
[64]
Gaspar L, Mascarenhas F, da Costa MS, et al.Radiation therapy in the unresectable cavernous hemangioma of the liver[J].Radiother Oncol,1993, 29(1): 45-50.DOI: 10.1016/0167-8140(93)90172-5.
[65]
Biswal BM, Sandhu M, Lal P, et al.Role of radiotherapy in cavernous hemangioma liver[J].Indian J Gastroenterol, 1995, 14(3): 95-98.
[66]
曾传发, 胡明道, 陈鹏, 等.肝海绵状血管瘤外科手术治疗的研究进展[J].世界最新医学信息文摘, 2019, 19(30): 159-161.DOI:10.19613/j.cnki.1671-3141.2019.30.072.
[67]
梁意球.肝血管瘤介入治疗中实施心理护理干预效果分析[J].中外医学研究, 2020, 18(35): 102-104.DOI: 10.14033/j.cnki.cfmr.2020.35.038.Liang YQ.Effect analysis of psychological nursing intervention in interventional therapy of hepatic hemangioma[J].Chin Foreign Med Res, 2020, 18(35): 102-104.DOI: 10.14033/j.cnki.cfmr.2020.35.038.
[68]
Goncharuk RA, Rakhmonov ZA, Stegnii KV, et al.Combined surgical treatment of giant cavernous hepatic hemangioma: a case report[J].Int J Surg Case Rep, 2022, 94: 107012.DOI: 10.1016/j.ijscr.2022.107012.
[69]
Wang LZ, Wang KP, Mo JG, et al.Minimally invasive treatment of hepatic hemangioma by transcatheter arterial embolization combined with microwave ablation: a case report[J].World J Clin Cases, 2021,9(24): 7154-7162.DOI: 10.12998/wjcc.v9.i24.7154.
[70]
Wang L, Li J, Song D, et al.Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma[J].Pediatr Surg Int, 2022, 38(8): 1149-1155.DOI: 10.1007/s00383-022-05143-w.
[1] 王昭雨, 姜军. 乳腺癌外科治疗理论和技术的发展与挑战[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(01): 1-5.
[2] 张祖强, 李圳, 刘勇, 王振龙. 双反牵引外固定架结合髓内钉治疗胫骨多段骨折的临床疗效及骨折愈合的影响因素分析[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(01): 13-21.
[3] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 1-8.
[4] 黄晋杰, 李奕男, 王彩琴, 黄晓卉, 王荣昌. 结直肠癌肺转移术后复发性肺转移治疗进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 50-54.
[5] 李国防, 陈凯, 管文贤, 刘颂. 消化道术后吻合口漏小鼠动物模型的建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 162-165.
[6] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[7] 陈洁莹, 许晶莹, 黄泽萍. 超声在女性压力性尿失禁诊断与疗效评估中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 14-20.
[8] 赵洪洲, 魏国先, 刘龙, 杨念宾, 李丹. 腹腔镜疝修补术与传统疝修补术治疗腹股沟疝的疗效及复发率比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 79-82.
[9] 乔宇, 李涛, 桑纯利, 董鑫. 奥希替尼联合TP 化疗方案对非小细胞肺癌的疗效及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(01): 149-152.
[10] 温盼, 李才坤, 何丹, 陈炎城. CT 引导活检与超声引导微波消融治疗直肠癌肺转移一例[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(01): 187-190.
[11] 姚焕章, 宋华传, 王永帅, 张珅瑜, 王继洲. 同期手术治疗同时性结直肠癌肝转移的安全性与疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 238-244.
[12] 张翀, 张宗明, 刘卓, 刘立民, 赵月, 齐晖. 肝门部胆管癌诊治进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 167-180.
[13] 卢亚, 王骥, 马红钦, 刘利, 杜羽升, 赵文星. 腹腔镜食管裂孔疝修补联合胆囊切除术的临床疗效[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 51-54.
[14] 汪小琳, 廖娟, 冯声蓉, 王毅, 金碧, 黄银平. 经腹超声黏膜下层指数结合血液炎症检查对中重度溃疡性结肠炎患者治疗效果的评价[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 60-64.
[15] 李娇娇, 回雪, 杨美荣, 周红军. 穴位电刺激联合中药脐部热熨辅助治疗脑卒中后便秘患者的疗效研究[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 69-72.
阅读次数
全文


摘要